200 related articles for article (PubMed ID: 25319834)
21. Tumour-induced osteomalacia.
Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
[TBL] [Abstract][Full Text] [Related]
22. Phosphaturic mesenchymal tumors: what an endocrinologist should know.
Boland JM; Tebben PJ; Folpe AL
J Endocrinol Invest; 2018 Oct; 41(10):1173-1184. PubMed ID: 29446010
[TBL] [Abstract][Full Text] [Related]
23. CD56 may be a more useful immunohistochemical marker than somatostatin receptor 2A for the diagnosis of phosphaturic mesenchymal tumors.
Tajima S; Fukayama M
Int J Clin Exp Pathol; 2015; 8(7):8159-64. PubMed ID: 26339384
[TBL] [Abstract][Full Text] [Related]
24. Phosphaturic mesenchymal tumor of the brain without tumor-induced osteomalacia in an 8-year-old girl: case report.
Ellis MB; Gridley D; Lal S; Nair GR; Feiz-Erfan I
J Neurosurg Pediatr; 2016 May; 17(5):573-7. PubMed ID: 26722864
[TBL] [Abstract][Full Text] [Related]
25. Tumor-induced osteomalacia.
Florenzano P; Gafni RI; Collins MT
Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
[TBL] [Abstract][Full Text] [Related]
26. Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss.
Ghorbani-Aghbolaghi A; Darrow MA; Wang T
Autops Case Rep; 2017; 7(3):32-37. PubMed ID: 29043208
[TBL] [Abstract][Full Text] [Related]
27. Tumor-induced osteomalacia in association with PTEN-negative Cowden syndrome.
Berglund JA; Gafni RI; Wodajo F; Cowen EW; El-Maouche D; Chang R; Chen CC; Guthrie LC; Molinolo AA; Collins MT
Osteoporos Int; 2018 Apr; 29(4):993-997. PubMed ID: 29380000
[TBL] [Abstract][Full Text] [Related]
28. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
29. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
[TBL] [Abstract][Full Text] [Related]
30. Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia.
Hartley IR; Roszko KL; Li X; Pozo K; Streit J; Del Rivero J; Magone MT; Smith MR; Vold R; Dambkowski CL; Collins MT; Gafni RI
JBMR Plus; 2022 Aug; 6(8):e10661. PubMed ID: 35991529
[TBL] [Abstract][Full Text] [Related]
31. Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings.
Shustik DA; Ng DC; Sittampalam K
Int J Clin Exp Pathol; 2015; 8(6):7506-17. PubMed ID: 26261662
[TBL] [Abstract][Full Text] [Related]
32. FN1-EGF gene fusions are recurrent in calcifying aponeurotic fibroma.
Puls F; Hofvander J; Magnusson L; Nilsson J; Haywood E; Sumathi VP; Mangham DC; Kindblom LG; Mertens F
J Pathol; 2016 Mar; 238(4):502-7. PubMed ID: 26691015
[TBL] [Abstract][Full Text] [Related]
33. Phosphaturic mesenchymal tumors: A review and update.
Folpe AL
Semin Diagn Pathol; 2019 Jul; 36(4):260-268. PubMed ID: 31301876
[TBL] [Abstract][Full Text] [Related]
34. A 50-Year-Old Man Presenting with Multiple Bone Lesions and a Diagnosis of Phosphaturic Mesenchymal Tumor of the Femur.
Ren D; Wei K; Ifegwu I
Am J Case Rep; 2024 Feb; 25():e942810. PubMed ID: 38361352
[TBL] [Abstract][Full Text] [Related]
35. Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis.
Uchihashi K; Nishijima-Matsunobu A; Matsuyama A; Yamasaki F; Tanabe T; Uemura T; Aragane N; Yakushiji M; Yamamoto M; Aoki S; Toda S
Hum Pathol; 2013 Nov; 44(11):2614-8. PubMed ID: 23954138
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.
Li F; Zhai YP; Tang YM; Wang LP; Wan PJ
Genes Chromosomes Cancer; 2012 Sep; 51(9):890-7. PubMed ID: 22619110
[TBL] [Abstract][Full Text] [Related]
37. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.
Bahrami A; Weiss SW; Montgomery E; Horvai AE; Jin L; Inwards CY; Folpe AL
Am J Surg Pathol; 2009 Sep; 33(9):1348-54. PubMed ID: 19609206
[TBL] [Abstract][Full Text] [Related]
38. Nodular fasciitis: a comprehensive, time-correlated investigation of 17 cases.
Sápi Z; Lippai Z; Papp G; Hegyi L; Sápi J; Dezső K; Szuhai K
Mod Pathol; 2021 Dec; 34(12):2192-2199. PubMed ID: 34381187
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
Lehnen NC; von Mässenhausen A; Kalthoff H; Zhou H; Glowka T; Schütte U; Höller T; Riesner K; Boehm D; Merkelbach-Bruse S; Kirfel J; Perner S; Gütgemann I
Histopathology; 2013 Aug; 63(2):157-66. PubMed ID: 23808822
[TBL] [Abstract][Full Text] [Related]
40. Possibility of D2-40 as a diagnostic and tumor differentiation-suggestive marker for some of phosphaturic mesenchymal tumors.
Tajima S; Fukayama M
Int J Clin Exp Pathol; 2015; 8(8):9390-6. PubMed ID: 26464693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
